Plato Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Buy
43,202
+2,772
+7% +$243K 0.22% 102
2026
Q1
$3.45M Buy
40,430
+14,702
+57% +$1.31M 0.23% 101
2025
Q4
$2.04M Hold
25,728
– – 0.13% 161
2025
Q3
$2.04M Hold
25,728
– – 0.14% 159
2025
Q2
$2.33M Buy
25,728
+21
+0.1% +$1.92K 0.18% 127
2025
Q1
$2.43M Buy
25,707
+177
+0.7% +$15.8K 0.21% 120
2024
Q4
$2.33M Buy
25,530
+5,378
+27% +$513K 0.17% 128
2024
Q3
$2.09M Hold
20,152
– – 0.17% 147
2024
Q2
$1.96M Buy
20,152
+1,311
+7% +$121K 0.18% 125
2024
Q1
$1.7M Buy
18,841
+16,706
+782% +$1.42M 0.18% 143
2023
Q4
$170K Buy
+2,135
New +$161K 0.21% 114

Other funds holding CL

Plato Investment Management's CL Position: Q2 2026 in Review

Plato Investment Management increased its Colgate-Palmolive (CL) stake by 6.9% in Q2 2026, buying an estimated $243K and bringing the position to 43,202 shares worth $3.94M. The position accounts for 0.22% of the portfolio, ranked #102.

Plato Investment Management first reported a position in CL in Q4 2023 and has held it in 11 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Plato Investment Management held 43,202 shares of Colgate-Palmolive worth $3.94M as of Q2 2026.
  • Plato Investment Management bought 2,772 Colgate-Palmolive shares in Q2 2026, an estimated $243K.
  • Colgate-Palmolive made up 0.22% of Plato Investment Management's portfolio in Q2 2026, its #102 holding.
  • Plato Investment Management first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.